Hoag is proud to now offer CyberKnife® as a technologically advanced
treatment option in the fight against cancer.
Hoag is collaborating with Newport Diagnostic Center (NDC) to offer another
minimally-invasive treatment option as part of Hoag’s comprehensive,
personalized and integrated approach to cancer treatment. The CyberKnife®
offers a renewed sense of hope to patients who may not be surgical candidates,
while often providing an excellent adjunct therapy for those patients
undergoing cancer surgery.
The CyberKnife is an FDA-cleared, non-invasive, robotic radiosurgery system
that treats both cancerous and non-cancerous tumors with sub-millimeter
accuracy. In the care of Hoag-affiliated Radiation Oncologist Amanda Schwer,
M.D., patients are treated in single or fractioned doses (typically in
1-5 sessions) by delivering multiple beams of precisely directed radiation
that converge upon the tumor, minimizing damage to surrounding healthy
tissue. With the unique ability to provide sub-millimeter precision and
thereby spare healthy tissue, the CyberKnife is often capable of safely
delivering curative doses in cases which were previously considered untreatable.
The CyberKnife is capable of treating tumors and lesions located in the
brain, spine, prostate, lung, liver and pancreas; virtually anywhere in the body.
Should your patient be faced with a cancer diagnosis, you can be assured
that Hoag will deliver the best treatment option for each specific patient.
Hoag also offers other minimally-invasive alternatives to surgical cancerous
tumor removal including Gamma Knife Perfexion®. Hoag has one of the
only Gamma Knife Perfexions® in Southern California and is the only
provider in Orange County offering both the CyberKnife and the Gamma Knife;
the two most technologically advanced stereotactic radiosurgery systems
in the world.
Through this new alliance, Hoag and
Newport Diagnostic Center are jointly providing CyberKnife radiosurgery in Newport Beach at 1605
Avocado Avenue. Newport Diagnostic Center established the world’s
first outpatient CyberKnife center and has been delivering CyberKnife
treatments to qualified patients since 1996. For more information, or
to determine if your patient is qualified for CyberKnife, please contact
Hazem Chehabi, M.D., medical director of Newport Diagnostic Center or
Amanda Schwer, M.D., Hoag-affiliated Radiation Oncologist, at 949-467-3061.